CTSO Cytosorbents | $1.11 +2.8% | 12/29/2023 | Reiterated by | HC Wainwright | - | Buy -> Neutral | $5.50 -> $1.00 | Low | View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 12/29/2023 |
ACRS Aclaris Therapeutics | $1.05 -1.9% | 12/29/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 12/29/2023 |
VRNA Verona Pharma | $19.88 -1.4% | 12/29/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 12/29/2023 |
CODX Co-Diagnostics | $1.33 -11.3% | 12/29/2023 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $3.00 | Low | View details for HC Wainwright rating of Co-Diagnostics (NASDAQ:CODX) on 12/29/2023 |
BCTX BriaCell Therapeutics | $5.85 +6.9% | 12/28/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 12/28/2023 |
ANY Sphere 3D | $3.32 +0.6% | 12/28/2023 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy | $5.00 | Low | View details for HC Wainwright rating of Sphere 3D (NASDAQ:ANY) on 12/28/2023 |
|
ZVRA Zevra Therapeutics | $6.55 +14.9% | 12/28/2023 | Reiterated by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | $10.00 -> $15.00 | Low | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 12/28/2023 |
VERA Vera Therapeutics | $15.38 -3.7% | 12/27/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Vera Therapeutics (NASDAQ:VERA) on 12/27/2023 |
CYTK Cytokinetics | $83.49 +0.3% | 12/27/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $58.00 -> $94.00 | Low | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 12/27/2023 |
BLTE Belite Bio | $45.75 -0.3% | 12/27/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 12/27/2023 |
IOVA Iovance Biotherapeutics | $8.13 -5.2% | 12/27/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $38.00 -> $28.00 | Low | View details for HC Wainwright rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 12/27/2023 |
CHRS Coherus BioSciences | $3.33 +2.8% | 12/27/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 12/27/2023 |
ONCT Oncternal Therapeutics | $0.54 +10.3% | 12/27/2023 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $2.00 | Low | View details for HC Wainwright rating of Oncternal Therapeutics (NASDAQ:ONCT) on 12/27/2023 |
GRCL Gracell Biotechnologies | $10.04 +1.1% | 12/26/2023 | Downgraded by | HC Wainwright | Analyst E. Bodnar | Buy -> Neutral | $13.00 -> $10.00 | Low | View details for HC Wainwright rating of Gracell Biotechnologies (NASDAQ:GRCL) on 12/26/2023 |
KRTX Karuna Therapeutics | $316.51 +0.1% | 12/26/2023 | Downgraded by | HC Wainwright | Analyst R. Selvaraju | Buy -> Neutral | $300.00 -> $330.00 | Low | View details for HC Wainwright rating of Karuna Therapeutics (NASDAQ:KRTX) on 12/26/2023 |
RVPH Reviva Pharmaceuticals | $5.15 +2.8% | 12/26/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 12/26/2023 |
TYRA Tyra Biosciences | $13.85 -0.4% | 12/26/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 | Low | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 12/26/2023 |
AXSM Axsome Therapeutics | $79.59 0.0% | 12/26/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/26/2023 |
EQ Equillium | $0.72 +5.9% | 12/26/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $4.50 -> $4.00 | Low | View details for HC Wainwright rating of Equillium (NASDAQ:EQ) on 12/26/2023 |
SNDX Syndax Pharmaceuticals | $21.61 +0.1% | 12/22/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $42.00 -> $41.00 | Low | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 12/22/2023 |
GAU Galiano Gold | $0.94 +1.1% | 12/22/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.20 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 12/22/2023 |
ALPN Alpine Immune Sciences | $19.06 -2.6% | 12/22/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $17.00 -> $32.00 | Low | View details for HC Wainwright rating of Alpine Immune Sciences (NASDAQ:ALPN) on 12/22/2023 |
LEGN Legend Biotech | $60.17 +0.6% | 12/22/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 12/22/2023 |
XOMA XOMA | $18.50 -2.3% | 12/22/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $74.00 | Low | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 12/22/2023 |
BHVN Biohaven | $42.80 -1.1% | 12/22/2023 | Initiated by | HC Wainwright | Analyst D. Tsao | Buy | $50.00 | Low | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 12/22/2023 |
FURY Fury Gold Mines | C$0.67 +4.7% | 12/21/2023 | Target Raised by | HC Wainwright | - | Buy | C$1.40 -> C$1.50 | N/A | View details for HC Wainwright rating of Fury Gold Mines (TSE:FURY) on 12/21/2023 |
CLNN Clene | $0.30 +7.2% | 12/21/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 12/21/2023 |
FURY Fury Gold Mines | $0.51 +4.1% | 12/21/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.40 -> $1.50 | N/A | View details for HC Wainwright rating of Fury Gold Mines (NYSEAMERICAN:FURY) on 12/21/2023 |
IVA Inventiva | $4.52 +0.4% | 12/21/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $36.00 -> $24.00 | Low | View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 12/21/2023 |
IMVT Immunovant | $42.13 -0.5% | 12/21/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $47.00 -> $51.00 | Low | View details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 12/21/2023 |
ARGX argenx | $380.43 +0.0% | 12/21/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $582.00 -> $451.00 | Low | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 12/21/2023 |
ETNB 89bio | $11.17 -1.5% | 12/20/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $35.00 -> $32.00 | Low | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 12/20/2023 |
MARA Marathon Digital | $23.49 -16.4% | 12/20/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $20.00 -> $24.00 | Low | View details for HC Wainwright rating of Marathon Digital (NASDAQ:MARA) on 12/20/2023 |
REE REE Automotive | $5.14 -1.3% | 12/19/2023 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy | $15.00 | Low | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 12/19/2023 |
KRON Kronos Bio | $1.25 +0.8% | 12/19/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $2.50 | Low | View details for HC Wainwright rating of Kronos Bio (NASDAQ:KRON) on 12/19/2023 |
RICK RCI Hospitality | $66.26 -1.4% | 12/19/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $115.00 | Low | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 12/19/2023 |
CARA Cara Therapeutics | $0.74 -2.6% | 12/19/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $7.00 -> $2.50 | Low | View details for HC Wainwright rating of Cara Therapeutics (NASDAQ:CARA) on 12/19/2023 |
CKPT Checkpoint Therapeutics | $2.29 +1.3% | 12/19/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $34.00 | Low | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 12/19/2023 |
UNCY Unicycive Therapeutics | $0.87 -1.1% | 12/19/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.50 | Low | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 12/19/2023 |
CRNX Crinetics Pharmaceuticals | $35.58 -0.5% | 12/19/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $42.00 | Low | View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 12/19/2023 |
|
VRDN Viridian Therapeutics | $21.78 -2.7% | 12/18/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $37.00 | Low | View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 12/18/2023 |
MIRM Mirum Pharmaceuticals | $29.52 -1.5% | 12/18/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $60.00 -> $58.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 12/18/2023 |
ITRG Integra Resources | $1.06
| 12/18/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | N/A | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 12/18/2023 |
ALNY Alnylam Pharmaceuticals | $191.41 -2.2% | 12/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $395.00 | Low | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/15/2023 |
TVTX Travere Therapeutics | $8.99 -4.5% | 12/15/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $18.00 -> $20.00 | Low | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 12/15/2023 |
CBAY CymaBay Therapeutics | $23.62 -1.5% | 12/15/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $24.00 -> $28.00 | Low | View details for HC Wainwright rating of CymaBay Therapeutics (NASDAQ:CBAY) on 12/15/2023 |
MYO Myomo | $5.01 -6.4% | 12/15/2023 | Initiated by | HC Wainwright | Analyst S. Lee | Buy | $6.50 | N/A | View details for HC Wainwright rating of Myomo (NYSEAMERICAN:MYO) on 12/15/2023 |
COGT Cogent Biosciences | $5.88 -2.8% | 12/15/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $27.00 -> $13.00 | Low | View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 12/15/2023 |
ACXP Acurx Pharmaceuticals | $3.83 -3.5% | 12/15/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $13.00 -> $14.00 | Low | View details for HC Wainwright rating of Acurx Pharmaceuticals (NASDAQ:ACXP) on 12/15/2023 |
AADI Aadi Bioscience | $2.02 -3.8% | 12/15/2023 | Downgraded by | HC Wainwright | Analyst R. Burns | Buy -> Neutral | | Low | View details for HC Wainwright rating of Aadi Bioscience (NASDAQ:AADI) on 12/15/2023 |
RPHM Reneo Pharmaceuticals | $1.60
| 12/15/2023 | Downgraded by | HC Wainwright | Analyst M. Kapoor | Buy -> Neutral | | Low | View details for HC Wainwright rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 12/15/2023 |
MBRX Moleculin Biotech | $0.86 +14.7% | 12/14/2023 | Reiterated by | HC Wainwright | Analyst V. Bernardino | Buy | $3.00 | Low | View details for HC Wainwright rating of Moleculin Biotech (NASDAQ:MBRX) on 12/14/2023 |
DRD DRDGOLD | $7.95 -0.9% | 12/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $17.00 -> $13.25 | Low | View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 12/13/2023 |
HARP Harpoon Therapeutics | $11.37 -0.6% | 12/13/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.50 -> $12.00 | Low | View details for HC Wainwright rating of Harpoon Therapeutics (NASDAQ:HARP) on 12/13/2023 |
ORIC ORIC Pharmaceuticals | $9.20
| 12/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $15.00 | Low | View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 12/13/2023 |
HLVX HilleVax | $16.05 -0.9% | 12/13/2023 | Initiated by | HC Wainwright | Analyst M. Caufield | Buy | $28.00 | Low | View details for HC Wainwright rating of HilleVax (NASDAQ:HLVX) on 12/13/2023 |
AXSM Axsome Therapeutics | $79.59 0.0% | 12/12/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/12/2023 |
SOUN SoundHound AI | $2.12 -4.9% | 12/11/2023 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 12/11/2023 |
HUMA Humacyte | $2.84 -4.4% | 12/11/2023 | Initiated by | HC Wainwright | Analyst V. Bernardino | Buy | $6.00 | Low | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 12/11/2023 |
PSTX Poseida Therapeutics | $3.36 -3.4% | 12/11/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $15.00 -> $20.00 | Low | View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 12/11/2023 |
RLAY Relay Therapeutics | $11.01 -2.8% | 12/11/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $19.00 -> $17.00 | Low | View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 12/11/2023 |
BPMC Blueprint Medicines | $92.24 +1.0% | 12/11/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $85.00 | Low | View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 12/11/2023 |
ENTX Entera Bio | $0.60 +9.1% | 12/11/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 12/11/2023 |
ETON Eton Pharmaceuticals | $4.38 -4.8% | 12/11/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 12/11/2023 |
VRTX Vertex Pharmaceuticals | $406.89 -0.6% | 12/11/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $390.00 -> $397.00 | Low | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/11/2023 |
GNFT Genfit | $3.85
| 12/8/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Genfit (NASDAQ:GNFT) on 12/8/2023 |
RIGL Rigel Pharmaceuticals | $1.45 -7.1% | 12/8/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 12/8/2023 |
KURA Kura Oncology | $14.38 +0.5% | 12/8/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 12/8/2023 |
UROY Uranium Royalty | $2.70 +2.3% | 12/8/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $6.20 -> $6.40 | Low | View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 12/8/2023 |
QSI Quantum-Si | $2.01 -11.5% | 12/8/2023 | Initiated by | HC Wainwright | Analyst S. Ramakanth | Buy | $3.00 | Low | View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 12/8/2023 |
SLDB Solid Biosciences | $6.14 -8.8% | 12/8/2023 | Initiated by | HC Wainwright | Analyst A. He | Buy | $9.00 | Low | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 12/8/2023 |
CELC Celcuity | $14.57 -0.3% | 12/8/2023 | Initiated by | HC Wainwright | Analyst S. Ramakanth | Buy | $27.00 | Low | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 12/8/2023 |
CERE Cerevel Therapeutics | $42.40 -0.1% | 12/7/2023 | Downgraded by | HC Wainwright | Analyst D. Tsao | Buy -> Neutral | $41.00 -> $45.00 | Low | View details for HC Wainwright rating of Cerevel Therapeutics (NASDAQ:CERE) on 12/7/2023 |
IGMS IGM Biosciences | $8.31 -5.5% | 12/7/2023 | Downgraded by | HC Wainwright | Analyst R. Burns | Buy -> Neutral | $11.00 -> $7.00 | Low | View details for HC Wainwright rating of IGM Biosciences (NASDAQ:IGMS) on 12/7/2023 |
CHRS Coherus BioSciences | $3.33 +2.8% | 12/7/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 12/7/2023 |
ANIX Anixa Biosciences | $3.88 -0.3% | 12/7/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 12/7/2023 |
USGO U.S. GoldMining | $7.31 -5.6% | 12/7/2023 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $22.00 -> $23.00 | Low | View details for HC Wainwright rating of U.S. GoldMining (NASDAQ:USGO) on 12/7/2023 |
IPSC Century Therapeutics | $3.32 +7.1% | 12/7/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Century Therapeutics (NASDAQ:IPSC) on 12/7/2023 |
BNOX Bionomics | $1.48 -4.5% | 12/7/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Bionomics (NASDAQ:BNOX) on 12/7/2023 |
CDTX Cidara Therapeutics | $0.79 -2.5% | 12/7/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 12/7/2023 |
LUMO Lumos Pharma | $3.18 +0.6% | 12/7/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of Lumos Pharma (NASDAQ:LUMO) on 12/7/2023 |
ACRX AcelRx Pharmaceuticals | $0.74 -9.8% | 12/7/2023 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of AcelRx Pharmaceuticals (NASDAQ:ACRX) on 12/7/2023 |
TRML Tourmaline Bio | $26.18 -5.3% | 12/4/2023 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy | | Low | View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 12/4/2023 |
EYPT EyePoint Pharmaceuticals | $23.11 -1.9% | 12/5/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $25.00 -> $35.00 | Low | View details for HC Wainwright rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 12/5/2023 |
ETNB 89bio | $11.17 -1.5% | 12/5/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 12/5/2023 |
TVTX Travere Therapeutics | $8.99 -4.5% | 12/5/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 12/5/2023 |
PRAX Praxis Precision Medicines | $22.28 +4.1% | 12/5/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 12/5/2023 |
RIOT Riot Platforms | $15.47 -12.1% | 12/5/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $18.00 -> $20.00 | N/A | View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 12/5/2023 |
MRNS Marinus Pharmaceuticals | $10.87 -1.1% | 12/5/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 12/5/2023 |
OKYO OKYO Pharma | $1.77 -6.3% | 12/5/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 12/5/2023 |
|
NR Newpark Resources | $6.64 -0.9% | 12/5/2023 | Initiated by | HC Wainwright | Analyst A. Dayal | Buy | $12.00 | Low | View details for HC Wainwright rating of Newpark Resources (NYSE:NR) on 12/5/2023 |
ASPI ASP Isotopes | $1.79 +1.7% | 12/5/2023 | Initiated by | HC Wainwright | Analyst H. Ihle | Buy | $3.25 | Low | View details for HC Wainwright rating of ASP Isotopes (NASDAQ:ASPI) on 12/5/2023 |
VALN Valneva | $10.37
| 12/4/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $26.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 12/4/2023 |
BTBT Bit Digital | $4.23 -16.9% | 12/4/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.00 -> $5.00 | Low | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 12/4/2023 |
SNSE Sensei Biotherapeutics | $0.69 -5.5% | 12/4/2023 | Reiterated by | HC Wainwright | Analyst E. White | Buy | $4.00 | Low | View details for HC Wainwright rating of Sensei Biotherapeutics (NASDAQ:SNSE) on 12/4/2023 |
LGVN Longeveron | $1.36 -2.2% | 12/4/2023 | Reiterated by | HC Wainwright | Analyst B. Pachaiyappan | Buy | $6.00 | Low | View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 12/4/2023 |
GANX Gain Therapeutics | $3.27 +11.2% | 12/4/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $9.00 | Low | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 12/4/2023 |
KRRO Korro Bio | $47.93 -2.5% | 12/4/2023 | Initiated by | HC Wainwright | Analyst M. Kapoor | Buy | $100.00 | Low | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 12/4/2023 |
SCLX Scilex | $2.04 +10.9% | 12/4/2023 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Scilex (NASDAQ:SCLX) on 12/4/2023 |
KZR Kezar Life Sciences | $0.95 -3.1% | 12/4/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 12/4/2023 |
COCP Cocrystal Pharma | $1.72 -1.7% | 12/4/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 12/4/2023 |
ALT Altimmune | $11.25 -3.2% | 12/1/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 12/1/2023 |
NEXCF Nextech3D.AI | $0.13 +8.5% | 11/30/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.00 -> $0.50 | Low | View details for HC Wainwright rating of Nextech3D.AI (OTCMKTS:NEXCF) on 11/30/2023 |
IMGN ImmunoGen | $29.65 -0.2% | 11/30/2023 | Downgraded by | HC Wainwright | Analyst S. Ramakanth | Buy -> Neutral | $28.00 -> $31.26 | N/A | View details for HC Wainwright rating of ImmunoGen (NASDAQ:IMGN) on 11/30/2023 |
PYXS Pyxis Oncology | $1.80 +0.6% | 11/30/2023 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy | $4.00 | Low | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 11/30/2023 |
PRTG Portage Biotech | $1.82 +12.3% | 11/29/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $6.00 | Low | View details for HC Wainwright rating of Portage Biotech (NASDAQ:PRTG) on 11/29/2023 |
CAN Canaan | $2.31 -17.8% | 11/29/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $4.00 -> $3.00 | Low | View details for HC Wainwright rating of Canaan (NASDAQ:CAN) on 11/29/2023 |
BITF Bitfarms | $2.91 -12.3% | 11/29/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.00 -> $4.00 | Low | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 11/29/2023 |
RICK RCI Hospitality | $66.26 -1.4% | 11/29/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $115.00 | Low | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 11/29/2023 |
CABA Cabaletta Bio | $22.70 -2.7% | 11/29/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 11/29/2023 |
CARM Carisma Therapeutics | $2.93 -4.6% | 11/29/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Carisma Therapeutics (NASDAQ:CARM) on 11/29/2023 |
ICCM IceCure Medical | $1.07 +7.0% | 11/29/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 11/29/2023 |
ARGX argenx | $380.43 +0.0% | 11/29/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $595.00 -> $582.00 | Low | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 11/29/2023 |
EDSA Edesa Biotech | $4.57 +1.8% | 11/29/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $70.00 -> $21.00 | Low | View details for HC Wainwright rating of Edesa Biotech (NASDAQ:EDSA) on 11/29/2023 |
RLYB Rallybio | $2.39 -4.4% | 11/29/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 | Low | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 11/29/2023 |
ERAS Erasca | $2.13 -3.2% | 11/28/2023 | Target Lowered by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $10.00 -> $8.00 | Low | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 11/28/2023 |
SWTX SpringWorks Therapeutics | $36.50 -2.0% | 11/28/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $52.00 -> $64.00 | Low | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/28/2023 |
AVXL Anavex Life Sciences | $9.31 -3.0% | 11/28/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 11/28/2023 |
ANVS Annovis Bio | $18.70 -4.4% | 11/28/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 11/28/2023 |
GMAB Genmab A/S | $31.84 -0.3% | 11/28/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $49.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 11/28/2023 |
FRLN Freeline Therapeutics | $6.37 +0.2% | 11/28/2023 | Downgraded by | HC Wainwright | Analyst P. Trucchio | Buy -> Neutral | $15.00 -> $6.50 | Low | View details for HC Wainwright rating of Freeline Therapeutics (NASDAQ:FRLN) on 11/28/2023 |
SLRN Acelyrin | $7.46 -2.2% | 11/28/2023 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 11/28/2023 |
ETNB 89bio | $11.17 -1.5% | 11/28/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 11/28/2023 |
ARCT Arcturus Therapeutics | $31.53 -4.4% | 11/28/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $51.00 | Low | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/28/2023 |
BRNS Barinthus Biotherapeutics | $3.69 +1.4% | 11/28/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 11/28/2023 |
KRON Kronos Bio | $1.25 +0.8% | 11/27/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Kronos Bio (NASDAQ:KRON) on 11/27/2023 |
MLTX MoonLake Immunotherapeutics | $60.39 -1.8% | 11/27/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/27/2023 |
KZR Kezar Life Sciences | $0.95 -3.1% | 11/27/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 11/27/2023 |
BNTX BioNTech | $105.54 -0.2% | 11/27/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $133.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 11/27/2023 |
CALT Calliditas Therapeutics AB (publ) | $25.74 +1.9% | 11/27/2023 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Calliditas Therapeutics AB (publ) (NASDAQ:CALT) on 11/27/2023 |
TRDA Entrada Therapeutics | $15.09 -8.0% | 11/27/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $25.00 -> $20.00 | Low | View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 11/27/2023 |
GNLX Genelux | $14.01 -13.5% | 11/27/2023 | Initiated by | HC Wainwright | Analyst E. Bodnar | Buy | $35.00 | Low | View details for HC Wainwright rating of Genelux (NASDAQ:GNLX) on 11/27/2023 |
NUVB Nuvation Bio | $1.51 -1.3% | 11/22/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.50 | Low | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 11/22/2023 |
BDTX Black Diamond Therapeutics | $2.81 -7.3% | 11/22/2023 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 11/22/2023 |
EDSA Edesa Biotech | $4.57 +1.8% | 11/22/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Edesa Biotech (NASDAQ:EDSA) on 11/22/2023 |
MDWD MediWound | $10.17 -1.0% | 11/22/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $26.00 | Low | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 11/22/2023 |
ARQQ Arqit Quantum | $0.47
| 11/22/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $4.00 -> $3.00 | Low | View details for HC Wainwright rating of Arqit Quantum (NASDAQ:ARQQ) on 11/22/2023 |
IREN Iris Energy | $7.15 -16.3% | 11/22/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $11.00 -> $10.00 | Low | View details for HC Wainwright rating of Iris Energy (NASDAQ:IREN) on 11/22/2023 |
SOL Emeren Group | $2.73 -1.4% | 11/22/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $7.00 | Low | View details for HC Wainwright rating of Emeren Group (NYSE:SOL) on 11/22/2023 |
CLDI Calidi Biotherapeutics | $1.51 +7.1% | 11/22/2023 | Initiated by | HC Wainwright | Analyst R. Burns | Buy | $11.00 | N/A | View details for HC Wainwright rating of Calidi Biotherapeutics (NYSEAMERICAN:CLDI) on 11/22/2023 |
|
CLDI Calidi Biotherapeutics | $1.51 +7.1% | 11/22/2023 | Initiated by | HC Wainwright | Analyst R. Burns | Buy | $11.00 | N/A | View details for HC Wainwright rating of Calidi Biotherapeutics (NYSEAMERICAN:CLDI) on 11/22/2023 |
PPBT Purple Biotech | $0.78 -4.9% | 11/21/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $9.00 -> $10.00 | Low | View details for HC Wainwright rating of Purple Biotech (NASDAQ:PPBT) on 11/21/2023 |
ENTA Enanta Pharmaceuticals | $9.41 -3.6% | 11/21/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $30.00 -> $28.00 | Low | View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 11/21/2023 |
BLRX BioLineRx | $1.57 +0.6% | 11/20/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 11/20/2023 |
BLNK Blink Charging | $3.39 -8.1% | 11/20/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 11/20/2023 |
YTRA Yatra Online | $1.63 +1.2% | 11/20/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Yatra Online (NASDAQ:YTRA) on 11/20/2023 |
GMAB Genmab A/S | $31.84 -0.3% | 11/20/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $49.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 11/20/2023 |
ADCT ADC Therapeutics | $1.66 +4.4% | 11/20/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.00 -> $3.00 | Low | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 11/20/2023 |
MYNZ Mainz Biomed | $1.16 -1.7% | 11/20/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $5.00 | Low | View details for HC Wainwright rating of Mainz Biomed (NASDAQ:MYNZ) on 11/20/2023 |
DRTS Alpha Tau Medical | $3.01 +6.4% | 11/20/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 11/20/2023 |
KRTX Karuna Therapeutics | $316.51 +0.1% | 11/20/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $300.00 | Low | View details for HC Wainwright rating of Karuna Therapeutics (NASDAQ:KRTX) on 11/20/2023 |
SPRB Spruce Biosciences | $2.93 +2.8% | 11/20/2023 | Reiterated by | HC Wainwright | Analyst B. Pachaiyappan | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Spruce Biosciences (NASDAQ:SPRB) on 11/20/2023 |
SWTX SpringWorks Therapeutics | $36.50 -2.0% | 11/20/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $58.00 -> $52.00 | Low | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/20/2023 |
APLM Apollomics | $0.97 +4.3% | 11/20/2023 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $17.00 | Low | View details for HC Wainwright rating of Apollomics (NASDAQ:APLM) on 11/20/2023 |
RPTX Repare Therapeutics | $7.30 -4.7% | 11/20/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Repare Therapeutics (NASDAQ:RPTX) on 11/20/2023 |
ELBM Electra Battery Materials | $0.37
| 11/20/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $2.50 -> $1.60 | Low | View details for HC Wainwright rating of Electra Battery Materials (NASDAQ:ELBM) on 11/20/2023 |
HIVE HIVE Digital Technologies | $4.53 -15.2% | 11/20/2023 | Downgraded by | HC Wainwright | Analyst M. Colonnese | Buy -> Neutral | $7.00 -> $3.50 | Low | View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 11/20/2023 |
DPRO Draganfly | $0.48 +4.4% | 11/17/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 | Low | View details for HC Wainwright rating of Draganfly (NASDAQ:DPRO) on 11/17/2023 |
CYBN Cybin | $0.41 +2.5% | 11/17/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $5.00 | N/A | View details for HC Wainwright rating of Cybin (NYSEAMERICAN:CYBN) on 11/17/2023 |
SLN Silence Therapeutics | $17.37 +2.1% | 11/17/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $80.00 -> $75.00 | Low | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 11/17/2023 |
KALA KALA BIO | $7.00 -5.8% | 11/17/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $24.00 -> $22.00 | Low | View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 11/17/2023 |
AKBA Akebia Therapeutics | $1.24 -3.1% | 11/17/2023 | Target Raised by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $3.75 -> $5.00 | Low | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 11/17/2023 |
ADMA ADMA Biologics | $4.52
| 11/17/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of ADMA Biologics (NASDAQ:ADMA) on 11/17/2023 |
GAU Galiano Gold | $0.94 +1.1% | 11/16/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $2.10 -> $2.20 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 11/16/2023 |
AREC American Resources | $1.49
| 11/16/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $3.50 -> $3.25 | Low | View details for HC Wainwright rating of American Resources (NASDAQ:AREC) on 11/16/2023 |
USAS Americas Silver | $0.25
| 11/16/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $1.50 | N/A | View details for HC Wainwright rating of Americas Silver (NYSEAMERICAN:USAS) on 11/16/2023 |
CLIR ClearSign Technologies | $1.11 -0.9% | 11/16/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of ClearSign Technologies (NASDAQ:CLIR) on 11/16/2023 |
GROY Gold Royalty | $1.47 -1.3% | 11/16/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.75 -> $5.50 | N/A | View details for HC Wainwright rating of Gold Royalty (NYSEAMERICAN:GROY) on 11/16/2023 |
ACLX Arcellx | $55.50 -2.4% | 11/15/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $50.00 -> $60.00 | Low | View details for HC Wainwright rating of Arcellx (NASDAQ:ACLX) on 11/15/2023 |
RMTI Rockwell Medical | $1.89 -3.1% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 11/15/2023 |
ARCT Arcturus Therapeutics | $31.53 -4.4% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $51.00 | Low | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/15/2023 |
LLAP Terran Orbital | $1.14 -6.6% | 11/15/2023 | Target Lowered by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $5.00 -> $3.00 | Low | View details for HC Wainwright rating of Terran Orbital (NYSE:LLAP) on 11/15/2023 |
ACXP Acurx Pharmaceuticals | $3.83 -3.5% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Acurx Pharmaceuticals (NASDAQ:ACXP) on 11/15/2023 |
ALNY Alnylam Pharmaceuticals | $191.41 -2.2% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $395.00 | Low | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/15/2023 |
PRAX Praxis Precision Medicines | $22.28 +4.1% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 11/15/2023 |
RWLK ReWalk Robotics | $0.78 +4.0% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:RWLK) on 11/15/2023 |
IPHA Innate Pharma | $2.80 +1.8% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.50 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 11/15/2023 |
ABSI Absci | $4.20 -8.7% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 11/15/2023 |
AFMD Affimed | $0.63 +16.8% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of Affimed (NASDAQ:AFMD) on 11/15/2023 |
BTAI BioXcel Therapeutics | $2.95 -1.7% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of BioXcel Therapeutics (NASDAQ:BTAI) on 11/15/2023 |
RAPT RAPT Therapeutics | $24.85 -2.4% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 | Low | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 11/15/2023 |
HOWL Werewolf Therapeutics | $3.86 -7.0% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Werewolf Therapeutics (NASDAQ:HOWL) on 11/15/2023 |
BLTE Belite Bio | $45.75 -0.3% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 11/15/2023 |
IGMS IGM Biosciences | $8.31 -5.5% | 11/15/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $17.00 -> $11.00 | Low | View details for HC Wainwright rating of IGM Biosciences (NASDAQ:IGMS) on 11/15/2023 |
YMAB Y-mAbs Therapeutics | $6.82 -7.7% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 11/15/2023 |
ALLO Allogene Therapeutics | $3.21 -1.8% | 11/15/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $23.00 -> $12.00 | Low | View details for HC Wainwright rating of Allogene Therapeutics (NASDAQ:ALLO) on 11/15/2023 |
CASI CASI Pharmaceuticals | $7.16 -0.4% | 11/15/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $12.00 | Low | View details for HC Wainwright rating of CASI Pharmaceuticals (NASDAQ:CASI) on 11/15/2023 |
GOEV Canoo | $0.26 -3.7% | 11/15/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $3.00 | Low | View details for HC Wainwright rating of Canoo (NYSE:GOEV) on 11/15/2023 |
GMDA Gamida Cell | $0.41 +2.5% | 11/15/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $11.00 -> $5.00 | Low | View details for HC Wainwright rating of Gamida Cell (NASDAQ:GMDA) on 11/15/2023 |
LEGN Legend Biotech | $60.17 +0.6% | 11/15/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $86.00 -> $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 11/15/2023 |
|
ASXC Asensus Surgical | $0.32 -5.9% | 11/15/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of Asensus Surgical (NYSEAMERICAN:ASXC) on 11/15/2023 |
EMX EMX Royalty | $1.62 +0.6% | 11/15/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.75 -> $5.75 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 11/15/2023 |
SENS Senseonics | $0.57
| 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | Low | View details for HC Wainwright rating of Senseonics (NYSE:SENS) on 11/14/2023 |
SABS SAB Biotherapeutics | $0.69
| 11/14/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $2.00 -> $1.00 | Low | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 11/14/2023 |
PHGE BiomX | $0.28 -3.4% | 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEAMERICAN:PHGE) on 11/14/2023 |
FEMY Femasys | $0.98 -3.9% | 11/14/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $13.00 -> $10.00 | Low | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 11/14/2023 |
BCDA BioCardia | $0.66 +1.5% | 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of BioCardia (NASDAQ:BCDA) on 11/14/2023 |
ACRS Aclaris Therapeutics | $1.05 -1.9% | 11/14/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $43.00 -> $9.00 | Low | View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/14/2023 |
EFTR eFFECTOR Therapeutics | $0.47 +2.2% | 11/14/2023 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of eFFECTOR Therapeutics (NASDAQ:EFTR) on 11/14/2023 |
BNTX BioNTech | $105.54 -0.2% | 11/14/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $180.00 -> $133.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 11/14/2023 |
TIL Instil Bio | $7.62 -0.5% | 11/14/2023 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $40.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 11/14/2023 |
RPHM Reneo Pharmaceuticals | $1.60
| 11/14/2023 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 11/14/2023 |
SPRO Spero Therapeutics | $1.47 +0.7% | 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 11/14/2023 |
EYEN Eyenovia | $2.08
| 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Eyenovia (NASDAQ:EYEN) on 11/14/2023 |
CLSD Clearside Biomedical | $1.17
| 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 11/14/2023 |
PLX Protalix BioTherapeutics | $1.78 -1.1% | 11/14/2023 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Protalix BioTherapeutics (NYSE:PLX) on 11/14/2023 |
KMDA Kamada | $6.12 -1.1% | 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Kamada (NASDAQ:KMDA) on 11/14/2023 |
STRO Sutro Biopharma | $4.29 -1.6% | 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 11/14/2023 |
UBX Unity Biotechnology | $1.93 +1.0% | 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 11/14/2023 |
OCUP Ocuphire Pharma | $3.01 -2.9% | 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Ocuphire Pharma (NASDAQ:OCUP) on 11/14/2023 |
BWEN Broadwind | $2.77 -5.5% | 11/14/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.00 -> $8.00 | Low | View details for HC Wainwright rating of Broadwind (NASDAQ:BWEN) on 11/14/2023 |
UEC Uranium Energy | $6.40 -0.6% | 11/14/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.25 | N/A | View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 11/14/2023 |
AKRO Akero Therapeutics | $23.35 -2.8% | 11/14/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 | Low | View details for HC Wainwright rating of Akero Therapeutics (NASDAQ:AKRO) on 11/14/2023 |
REPL Replimune Group | $8.43 -1.9% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $50.00 -> $48.00 | Low | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 11/13/2023 |
AADI Aadi Bioscience | $2.02 -3.8% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $45.00 -> $36.00 | Low | View details for HC Wainwright rating of Aadi Bioscience (NASDAQ:AADI) on 11/13/2023 |
RVMD Revolution Medicines | $28.68 -2.3% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $32.00 -> $28.00 | Low | View details for HC Wainwright rating of Revolution Medicines (NASDAQ:RVMD) on 11/13/2023 |
XERS Xeris Biopharma | $2.35 -0.4% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $6.00 -> $5.50 | Low | View details for HC Wainwright rating of Xeris Biopharma (NASDAQ:XERS) on 11/13/2023 |
INAB IN8bio | $1.38 -2.8% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 11/13/2023 |
ACIU AC Immune | $5.00 +3.3% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 11/13/2023 |
DBVT DBV Technologies | $0.95 -4.0% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of DBV Technologies (NASDAQ:DBVT) on 11/13/2023 |
ONCY Oncolytics Biotech | $1.35 -0.7% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $5.00 | Low | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 11/13/2023 |
SVRA Savara | $4.70 -2.5% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Savara (NASDAQ:SVRA) on 11/13/2023 |
OMGA Omega Therapeutics | $3.01 -2.9% | 11/13/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $11.00 -> $12.00 | Low | View details for HC Wainwright rating of Omega Therapeutics (NASDAQ:OMGA) on 11/13/2023 |
ESPR Esperion Therapeutics | $2.99 -2.9% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 11/13/2023 |
MGNX MacroGenics | $9.62 -3.2% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $14.00 -> $12.00 | Low | View details for HC Wainwright rating of MacroGenics (NASDAQ:MGNX) on 11/13/2023 |
ANVS Annovis Bio | $18.70 -4.4% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $40.00 -> $30.00 | Low | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 11/13/2023 |
EQ Equillium | $0.72 +5.9% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $5.50 -> $4.50 | Low | View details for HC Wainwright rating of Equillium (NASDAQ:EQ) on 11/13/2023 |
SLGL Sol-Gel Technologies | $1.11 -12.0% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.00 -> $9.00 | Low | View details for HC Wainwright rating of Sol-Gel Technologies (NASDAQ:SLGL) on 11/13/2023 |
CADL Candel Therapeutics | $1.47 +5.8% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 11/13/2023 |
MDGL Madrigal Pharmaceuticals | $231.38 -1.1% | 11/13/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $225.00 -> $275.00 | Low | View details for HC Wainwright rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 11/13/2023 |
SRTS Sensus Healthcare | $2.36 -1.7% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Sensus Healthcare (NASDAQ:SRTS) on 11/13/2023 |
CODX Co-Diagnostics | $1.33 -11.3% | 11/13/2023 | Target Raised by | HC Wainwright | - | Neutral -> Neutral | $2.00 -> $3.00 | Low | View details for HC Wainwright rating of Co-Diagnostics (NASDAQ:CODX) on 11/13/2023 |
JANX Janux Therapeutics | $10.73 -8.3% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of Janux Therapeutics (NASDAQ:JANX) on 11/13/2023 |
MAG MAG Silver | $10.41 -1.5% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.50 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 11/13/2023 |
BTCS BTCS | $1.63 -29.7% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of BTCS (NASDAQ:BTCS) on 11/13/2023 |
NMG Nouveau Monde Graphite | $2.61 +4.0% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $8.00 | Low | View details for HC Wainwright rating of Nouveau Monde Graphite (NYSE:NMG) on 11/13/2023 |
ELDN Eledon Pharmaceuticals | $1.80 -3.2% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 11/13/2023 |
DYAI Dyadic International | $1.61 +2.5% | 11/13/2023 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Dyadic International (NASDAQ:DYAI) on 11/13/2023 |
BOXL Boxlight | $1.07 -0.9% | 11/13/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $6.00 -> $3.00 | Low | View details for HC Wainwright rating of Boxlight (NASDAQ:BOXL) on 11/13/2023 |
BLNK Blink Charging | $3.39 -8.1% | 11/10/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $50.00 -> $25.00 | Low | View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 11/10/2023 |
RLYB Rallybio | $2.39 -4.4% | 11/10/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $18.00 -> $17.00 | Low | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 11/10/2023 |
TARS Tarsus Pharmaceuticals | $20.25 -2.3% | 11/10/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $42.00 -> $50.00 | Low | View details for HC Wainwright rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 11/10/2023 |
CABA Cabaletta Bio | $22.70 -2.7% | 11/10/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $17.00 -> $25.00 | Low | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 11/10/2023 |
DARE Daré Bioscience | $0.31 -6.1% | 11/10/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $7.00 -> $6.00 | Low | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 11/10/2023 |
AMLX Amylyx Pharmaceuticals | $14.72 -0.2% | 11/10/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $50.00 -> $42.00 | Low | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 11/10/2023 |
VALN Valneva | $10.37
| 11/10/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $22.00 -> $26.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 11/10/2023 |
LGO Largo | $2.31 -1.7% | 11/10/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.00 -> $9.00 | Low | View details for HC Wainwright rating of Largo (NYSE:LGO) on 11/10/2023 |
MUX McEwen Mining | $7.21 -1.9% | 11/10/2023 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $20.50 -> $18.50 | Low | View details for HC Wainwright rating of McEwen Mining (NYSE:MUX) on 11/10/2023 |
ASM Avino Silver & Gold Mines | $0.52 -0.9% | 11/10/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.70 -> $1.80 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 11/10/2023 |
ASM Avino Silver & Gold Mines | $0.52 -0.9% | 11/10/2023 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.70 -> $1.80 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 11/10/2023 |